Daily Anesthesiology Research Analysis
Analyzed 56 papers and selected 3 impactful papers.
Summary
Three impactful anesthesiology-related studies stood out: a mechanistic mouse study implicating an HDAC7–NF-κB–MFN2–ACSL4 ferroptosis pathway in perioperative neurocognitive disorders; a 13,143-patient cohort identifying distinct intraoperative hemodynamic phenotypes linked to graded postoperative complications; and an ICU database analysis associating propofol (vs midazolam) sedation with lower 30-day mortality in sepsis-associated acute kidney injury, partly mediated by metabolic acidosis.
Research Themes
- Mechanistic drivers and targets of perioperative neurocognitive disorders (ferroptosis signaling)
- Intraoperative hemodynamic phenotyping and postoperative risk stratification
- ICU sedation strategy in sepsis-associated AKI and acid–base mediation
Selected Articles
1. Hippocampal HDAC7 induces perioperative neurocognitive disorders via an NF-κB-MFN2-ACSL4 ferroptosis pathway.
In an aged-mouse tibial fracture model, hippocampal HDAC7 and phosphorylated NF-κB increased 3 days post-surgery. AAV-shRNA knockdown of HDAC7 reduced NF-κB activation, ameliorated mitochondrial injury, restored MFN2, reversed ACSL4 upregulation and GPX4 loss, and normalized ferroptosis markers, implicating an HDAC7–NF-κB–MFN2–ACSL4 ferroptosis pathway in perioperative neurocognitive disorders.
Impact: This study delineates a mechanistic ferroptosis pathway driving perioperative neurocognitive disorders and identifies HDAC7 as an upstream modulator, highlighting druggable targets for prevention strategies.
Clinical Implications: Although preclinical, the data support exploring HDAC7 inhibition and ferroptosis-targeted therapies (e.g., ACSL4 inhibition, GPX4 preservation) to prevent postoperative cognitive decline in older adults.
Key Findings
- Surgery in aged mice increased hippocampal HDAC7 and phosphorylated NF-κB in CA3 at day 3.
- HDAC7 knockdown via AAV-shRNA reduced NF-κB activation, alleviated mitochondrial injury, and restored MFN2.
- Ferroptosis signatures (ACSL4 up, GPX4 loss, related markers) were reversed by HDAC7 knockdown, implicating an NF-κB–MFN2–ACSL4 pathway.
Methodological Strengths
- Use of an aged in vivo surgical model relevant to perioperative cognition
- Targeted gene knockdown (AAV-shRNA) with multi-dimensional readouts (mitochondrial integrity, ferroptosis markers)
Limitations
- Preclinical mouse model limits direct clinical generalizability
- Behavioral and long-term cognitive outcomes are not detailed in the abstract
Future Directions: Translate findings to human biomarker studies of ferroptosis in PND and test HDAC7/ferroptosis inhibitors in perioperative prevention trials.
Perioperative neurocognitive disorders (PND) are common complications in elderly surgical patients, yet the molecular mechanisms underlying this condition remain poorly understood. Accumulating evidence suggests that HDAC7-a member of the class IIa histone deacetylase (HDAC) family-plays a crucial role in brain injury and can activate the NF-κB pathway independently of its deacetylase activity. In the present study, we investigated whether upregulation of hippocampal HDAC7 contributes to PND through NF-κB-mediated mitochondrial dysfunction and ferroptosis. A tibial fracture model was established in 18-month-old mice, and elevated levels of HDAC7 and phosphorylated NF-κB (P-NF-κB) were detected in the hippocampal CA3 region 3 days after surgery. Moreover, bilateral injections of HDAC7 AAV-shRNA into the CA3 region reduced P-NF-κB levels and alleviated mitochondrial damage. HDAC7 knockdown restored mitofusin 2 (MFN2) expression, reversed the upregulation of acyl-CoA synthetase long-chain family member 4 (ACSL4) and the loss of glutathione peroxidase 4 (GPX4), normalized the levels of ferroptosis-related markers (Fe
2. Distinct patterns of intraoperative hemodynamic behavior and postoperative outcomes after major abdominal surgery.
Using invasive MAP time series, vasopressor use, and fluids, unsupervised clustering identified four intraoperative phenotypes with graded risks: from stable hemodynamics to sustained hypotension with high vasopressors. AKI rose from 4.9% to 41.4%, ICU admission from 8.3% to 93.2%, and mortality from 0.7% to 6.0% across phenotypes, with adjusted models confirming higher odds in intermediate-risk groups.
Impact: This large cohort links data-driven intraoperative hemodynamic patterns to postoperative complications, enabling risk stratification beyond single-threshold hypotension metrics.
Clinical Implications: Phenotype-aware intraoperative management could prioritize hypotension avoidance, guide vasopressor/fluid strategies, and inform postoperative ICU triage for high-risk phenotypes.
Key Findings
- Four intraoperative hemodynamic phenotypes were derived from MAP, hypotension burden, vasopressors, and fluids.
- Outcomes displayed a graded pattern: AKI 4.9% (stable) to 41.4% (sustained hypotension/high vasopressors); ICU 8.3% to 93.2%; mortality 0.7% to 6.0%.
- Adjusted models showed phenotypes 2–3 had ~2–3× higher odds of AKI and ICU admission compared with the stable phenotype.
Methodological Strengths
- Very large sample with continuous invasive blood pressure monitoring
- Unsupervised clustering with adjusted regression controlling for key confounders
Limitations
- Single-center retrospective design limits generalizability
- Unmeasured confounding and clustering choices may influence phenotype definitions
Future Directions: Prospectively validate phenotypes and test phenotype-tailored hemodynamic interventions to reduce AKI and ICU utilization.
STUDY OBJECTIVE: To determine whether routinely recorded intraoperative hemodynamic data can identify clinically meaningful patterns associated with postoperative complications after major abdominal surgery. DESIGN: Retrospective observational cohort study. SETTING: Single tertiary academic center; analysis of the INSPIRE perioperative research database. PATIENTS: 13,143 adult patients undergoing elective major abdominal surgery with continuous invasive arterial pressure monitoring. INTERVENTIONS: None. MEASUREMENTS: Intraoperative hemodynamics were summarized using median mean arterial pressure (MAP), percentage of measurements with MAP <65 mmHg, vasopressor use, and fluid administration. Unsupervised k-means clustering was used to derive intraoperative hemodynamic phenotypes. Associations with postoperative acute kidney injury (AKI), intensive care unit (ICU) admission, in-hospital mortality, and hospital length of stay were assessed using adjusted regression models controlling for age, sex, body mass index, ASA physical status, and surgical department. MAIN RESULTS: Four distinct intraoperative hemodynamic patterns were identified. Most procedures were hemodynamically stable (phenotype 1, 63.9%). Two intermediate (phenotype 2 and 3; 35.0% combined) were characterized by greater hypotension burden with increased vasopressor or fluid requirements. A small group (phenotype 4, 1.0%) showed sustained hypotension and high vasopressor use. Postoperative outcomes followed a graded pattern: AKI increased from 4.9% in phenotype 1 to 41.4% in phenotype 4, ICU admission from 8.3% to 93.2%, and in-hospital mortality from 0.7% to 6.0%. After adjustment, phenotypes 2 and 3 were associated with approximately two- to threefold higher odds of AKI and ICU admission compared with phenotype 1. CONCLUSIONS: Distinct intraoperative hemodynamic phenotypes are associated with graded increases in postoperative complications after major abdominal surgery.
3. Propofol versus Midazolam With 30-Day Mortality in Sepsis-Associated Acute Kidney Injury: A MIMIC-IV Analysis.
In 3,335 S-AKI ICU patients, midazolam monotherapy and midazolam+propofol were associated with higher 30-day mortality versus propofol alone, consistent after IPTW. Mediation analysis suggested metabolic acidosis partially mediates midazolam-associated excess risk.
Impact: Provides comparative real-world evidence favoring propofol over benzodiazepine-based sedation in S-AKI and proposes a plausible acid–base mechanism.
Clinical Implications: When feasible, prefer propofol monotherapy over midazolam for sedation in S-AKI; closely monitor and correct metabolic acidosis, especially if benzodiazepines are used.
Key Findings
- Midazolam monotherapy (HR 1.945) and combination therapy (HR 1.573) had higher 30-day mortality risk vs propofol monotherapy after adjustment.
- Results were consistent after inverse probability of treatment weighting and across subgroups.
- Metabolic acidosis significantly mediated part of midazolam-associated mortality risk (≈16% alone; ≈10% combined).
Methodological Strengths
- Large ICU database with multivariable, IPTW, and subgroup analyses
- Mediation analysis probing pathophysiologic mechanisms
Limitations
- Observational design susceptible to confounding by indication and exposure misclassification
- Sedation depth, dosing nuances, and co-interventions may not be fully captured
Future Directions: Prospective trials comparing propofol- vs benzodiazepine-based sedation in sepsis and AKI; interventional strategies to mitigate metabolic acidosis during sedation.
INTRODUCTION: Propofol and midazolam are commonly used sedatives in patients with sepsis-associated acute kidney injury (S-AKI), yet the association of their combined use on patient prognosis remains unclear. This study aimed to compare the associations of propofol monotherapy, midazolam monotherapy, and their combination with 30-day mortality in S-AKI patients. METHODS: This study analyzed 3335 S-AKI patients from the Medical Information Mart for Intensive Care IV database, categorized by sedation strategy: no sedation, propofol alone, midazolam alone, or combination therapy. The primary outcome was 30-day all-cause mortality. Associations were assessed using Kaplan-Meier survival analysis, Cox proportional hazards models, and inverse probability of treatment weighting. Subgroup and mediation analyses were also performed. RESULTS: After multivariable adjustment, both midazolam monotherapy (hazard ratio [HR] = 1.945, 95% confidence interval: 1.519-2.490) and combination therapy (HR = 1.573, 95% confidence interval: 1.275-1.942) were associated with significantly increased 30-day mortality risk compared to propofol monotherapy. This finding was consistent after inverse probability of treatment weighting (HR = 1.742 and 1.328, respectively). Subgroup analyses generally supported this trend across different populations. Mediation analysis indicated that metabolic acidosis significantly mediated part of the increased mortality risk associated with midazolam (alone: 15.84%; combined: 10.21%). CONCLUSIONS: Propofol monotherapy was associated with more significant survival benefits compared to midazolam monotherapy or combination therapy. Metabolic acidosis is a key pathological mechanism mediating this difference, which has important guiding value for improving the prognosis of this high-risk population.